Table 2.
Complications after transrectal prostate biopsy of patients between 01/2018 and 05/2019 stratified for SB and SB + TB.
| Variable | Overall | SB | TB + SB | p-value | |
|---|---|---|---|---|---|
| Patients subjectively reported about complications after biopsy, n (%): | No | 161 (89.4) | 76 (90.5) | 85 (88.5) | 0.631 |
| Yes | 16 (8.9) | 6 (7.1) | 10 (10.4) | ||
| Undecided | 3 (1.7) | 2 (2.4) | 1 (1.1) | ||
| Patient would choose the same approach in another biopsy, n (%): | Yes | 163 (90.6) | 77 (91.7) | 86 (89.6) | 0.947 |
| No | 12 (6.7) | 5 (6) | 7 (7.3) | ||
| Undecided | 2 (1.1) | 1 (1.2) | 1 (1) | ||
| Unknown | 3 (1.7) | 1 (1.2) | 2 (2.1) | ||
| Gross hematuria (in days after biopsy), n (%) | 0–1 | 148 (82.2) | 69 (82.1) | 79 (82.3) | 0.532 |
| 2–5 | 12 (6.7) | 4 (4.8) | 8 (8.3) | 0 | |
| 5–10 | 9 (5) | 4 (4.8) | 5 (5.2) | 0 | |
| >14 | 11 (6.2) | 7 (8.4) | 4 (4.1) | 0 | |
| Hematospermia (in days after biopsy), n (%) | 0–1 | 155 (86.1) | 73 (86.9) | 82 (85.4) | 0.942 |
| >1 | 25 (13.9) | 11 (13.1) | 14 (14.6) | ||
| Rectal bleeding (in days after biopsy), n (%) | 0–1 | 175 (97.2) | 82 (97.6) | 93 (96.9) | 0.999 |
| 2–3 | 4 (2.3) | 1 (1.2) | 3 (3.1) | 0.172 | |
| >14 | 1 (0.6) | 1 (1.2) | (0) | ||
| Sacral/gluteal pain, n (%) | No | 176 (97.8) | 84 (100) | 92 (95.8) | 0.166 |
| Yes | 4 (2.2) | 0 (0) | 4 (4.2) | ||
| Fever after biopsy, n (%) | 1 (0.6) | 1 (1.2) | 0 (0) | 0.317 | |
| Physician consultation after biopsy? n (%) | No | 176 (97.6) | 82 (97.6) | 94 (97.9) | 0.999 |
| Yes | 4 (2.4) | 2 (2.4) | 2 (2.1) | ||
| Reason of consultation, n (%) | Hematuria | 1 (0.6) | 0 (0) | 1 (1) | 0.401 |
| Rectal bleeding | 1 (0.6) | 0 (0) | 1 (1) | ||
| Urinary retention | 1 (0.6) | 1 (1.2) | 0 (0) | ||
| Unknown | 1 (0.6) | 1 (1.2) | 0 (0) |
SB, systemic biopsy; TB, targeted biopsy.